Strength

236; 2.97; 6.74; 5.86; 22.74 g/4L; g/4L; g/4L; g/4L; g/4L

NDC

10572010001

Classification

Generic

Dosage Form

POWDER, FOR SOLUTION

Route

ORAL

Last Updated

4/22/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA019011

On Market Since

7/1/2009

Pharmacological Classes

Increased Large Intestinal Motility
Increased Large Intestinal Motility
Increased Large Intestinal Motility
Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Activity
Osmotic Activity
Osmotic Activity
Osmotic Activity
Osmotic Laxative
Osmotic Laxative
Osmotic Laxative
Osmotic Laxative
Osmotic Laxative
Potassium Compounds
Potassium Salt
Stimulation Large Intestine Fluid/Electrolyte Secretion

Price History

1W

0.0%

1M

+3.1%

3M

+6.4%

6M

+4.3%

1Y

+1.1%

3Y

+8.4%

5Y

+65.5%

All

+60.3%